U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C3H7O6P.2K
Molecular Weight 248.2544
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of POTASSIUM 2-GLYCEROPHOSPHATE

SMILES

[K+].[K+].OCC(CO)OP([O-])([O-])=O

InChI

InChIKey=KOJMAGAPHTUHAC-UHFFFAOYSA-L
InChI=1S/C3H9O6P.2K/c4-1-3(2-5)9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;/q;2*+1/p-2

HIDE SMILES / InChI

Molecular Formula K
Molecular Weight 39.0983
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C3H7O6P
Molecular Weight 170.0578
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Potassium Glycerophosphate is a source of potassium. It is used in the treatment of nutritional deficiencies. Potassium supplements can be an important part of the recovery from or prevention of many different ailments and diseases. The most common of these include helping lower blood pressure and serving as a stroke preventative. Potassium can also be used to lower levels of calcium, to help with certain diseases including Alzheimer’s and Meniere’s. It may also help with some more common issues such as a common allergy, migraines, heavy acne, alcohol abuse, dizziness and confusion, extreme fatigue, recurring constipation, insomnia, anger and aggression, irregular heartbeat and stress. Potassium can either be taken as a supplement by mouth or it can be given intravenously to certain patients who require a faster dosing of the mineral or cannot take it orally.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Minadex

Approved Use

As a treatment for vitamin and mineral deficiency and as an appetite stimulant during and after illness

Launch Date

8.0559361E11
PubMed

PubMed

TitleDatePubMed
Preservation of rat liver nuclei by potassium glycerophosphate.
1955 Dec 10
Patents

Sample Use Guides

In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:53:32 UTC 2023
Edited
by admin
on Fri Dec 15 15:53:32 UTC 2023
Record UNII
31S538FVCY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
POTASSIUM 2-GLYCEROPHOSPHATE
Common Name English
POTASSIUM GLYCERYL-2-PHOSPHATE
Common Name English
GLYCERO-2-PHOSPHATE, POTASSIUM SALT
Common Name English
Code System Code Type Description
CAS
74493-87-1
Created by admin on Fri Dec 15 15:53:32 UTC 2023 , Edited by admin on Fri Dec 15 15:53:32 UTC 2023
PRIMARY
FDA UNII
31S538FVCY
Created by admin on Fri Dec 15 15:53:32 UTC 2023 , Edited by admin on Fri Dec 15 15:53:32 UTC 2023
PRIMARY
EPA CompTox
DTXSID80225496
Created by admin on Fri Dec 15 15:53:32 UTC 2023 , Edited by admin on Fri Dec 15 15:53:32 UTC 2023
PRIMARY
PUBCHEM
71587271
Created by admin on Fri Dec 15 15:53:32 UTC 2023 , Edited by admin on Fri Dec 15 15:53:32 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
SOLVATE->ANHYDROUS